Keith Berelowitz (Director of Operations)

A scientist by training, Keith has worked in clinical research (academic and commercial) for over 14 years, having spent the majority of that period working for Richmond Pharmacology. In his role as Director of Operations at Richmond Pharmacology he is focused on the efficient conduct of all functions within the company whilst ensuring maintenance of quality standards.

Having played an operational role in over 150 studies, across the commercial, project and recruitment related management of these studies, his specialist area of interest has focused on the assessment and understanding of the feasibility of conducting early phase patient trials in a phase I environment. Keith has worked with a number of sponsors advising them on the viability of conducting such trials within the UK, a number of which have gone on to be conducted successfully with Richmond Pharmacology.

He is a member of the National Research Ethics Service Phase I Advisory Group (Health Research Authority, UK), the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI, UK), Chairperson of the EUCROF Early Phase Working Group, the UK representative of the EUCROF Extended Executive Board, and a Member of the Executive Board of the Clinical Contract Research Association (CCRA).

Go back to experts


More on our Specialist Services

Latest news

Echocardiography Course undertaken at Richmond Pharmacology

13th Mar 2019

Richmond Pharmacology CEO, Dr Jorg Taubel, Franklin Gordon, Resuscitation Simulation & Clinical Skills Practitioner

Read more ›

Richmond Pharmacology, Medical Director, Dr Lorch welcomes new Clinical Pharmacology Apprentice scheme

06th Feb 2019

Significant work has been undertaken to push forward the launch of a new apprentice scheme aimed at raising the

Read more ›

Dr Arezina article published in GMP review

16th Aug 2018

Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review

Read more ›

Contemporary Imaging in Early Phase Clinical Trials

Richmond Pharmacology will be holding an event to show how the effective use of Contemporary Imaging and a

View event ›